Instead, blockade of IFNβ but not IFNα improved splenic architecture, decreased infection of CD8α− DC, and enhanced antiviral T cell responses that led to clearance of persistent virus, mimicking many of the effects seen with IFNAR1 blockade. The gene discussed is IFNA2; the disease is infection.